Global Cardiac Biomarker Market Research and Forecast 2018-2023

  • ID: 4471497
  • Report
  • Region: Global
  • Orion Market Research Private Limited
1 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Becton, Dickson & Co.
  • Biomerieux
  • Cisbio Bioassays
  • Critical Diagnostics
  • Luminex Corporation
  • MORE
The global cardiac biomarker market is anticipated to grow at a CAGR of 7.1% by 2023. There are several drivers that are driving the cardiac biomarker market globally such as rise in the cardiovascular diseases, rise in the geriatric population, and technological development. Rise in the geriatric population and the rise in the cardiac vascular diseases are the major factors that affect the growth of the market as the biomarkers are utilized for detection of the cardiac problems. According to the World Health Organization, in 2015, around17.7 million of people died due to cardio vascular diseases out of these 7.4 million were affected due to coronary heart diseases and an approximately 6.7 million due to heart stroke. The cardiac biomarkers are utilized to detect and measure the risk factor associated with heart diseases. The cardiac biomarkers been successfully tested to provide more accurate prediction of heart failure after chest pain compared to more conventional methods. This is a major factor which may fuel the growth of the market. The market is also affected by technological development of cardiac biomarker.

The cardiac biomarker has been segmented on the basis of by type, by application and by location of testing. By type, the market is bifurcated into Creatine Kinase (CK-MB), troponins (T,I), myoglobin, natriuretic peptides( BNP& NT-proBNP), ischemia modified albumin and others. According to application, the market is bifurcated into myocardial infraction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. By location of testing, the market is segmented into Point of care(POC) testing and laboratory testing.

Geographically, the worldwide cardiac biomarker showcase is divided into North America, Europe, Asia-Pacific, and the Rest of the World. Asia Pacific market is considered to be the fastest growing market globally. The rise in the number of cardiovascular patients in the APAC region is considered to rise eventually that enable the cardiac biomarker market to grow. The North America and Europe are considered to be the dominating markets due to various factors such as high healthcare expenditure, development in the technology, support from government, and rise in the key players

The key players in the cardiac biomarker market Include Abbott Diagnostics, Alere Inc., Becton, Dickson & Co., Bg Medicine Inc., Biomerieux, Bio-Rad Laboratories, Cisbio Bioassays, Covance, Critical Diagnostics, Lifesign, Luminex Corporation, Randox laboratories Ltd., Response Biomedical Corporation, Roche Holding Ag, Siemens Healthcare, Signosis Inc., Thermo Fisher Scientific Inc.

Market Segmentation:

Global cardiac biomarker market is segmented on the basis of, type, by application, by location of testing and regional outlook.
  • Global Cardiac Biomarker Market Research and Analysis, By Type
  • Global Cardiac Biomarker Market Research and Analysis, By Application
  • Global Cardiac Biomarker Market Research and Analysis, By Location of Testing
  • Global Cardiac Biomarker Market Research and Analysis, By Region
The Reports Covers:
  • Comprehensive research methodology of Global Cardiac biomarker
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Cardiac biomarker
  • Insights about market determinants which are stimulating the Global Cardiac biomarker
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Becton, Dickson & Co.
  • Biomerieux
  • Cisbio Bioassays
  • Critical Diagnostics
  • Luminex Corporation
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. by Segments
1.2.2. by Geography
1.2.3. by Stakeholders

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World
2.4. Patent Analysis

3. Market Determinant
3.1. Motivators
3.1.1. Rising Number of Cardiovascular Diseases
3.1.2. Technological Advancement Related to Biomarkers
3.1.3. Robust Health Care Expenditure and High Investments Made for the Research and Development in Developed Economies
3.1.4. Urgent Need for a More Accurate Form of Diagnosis
3.2. Restraints
3.2.1. High Capital Investments is Required and Profit Ratio is Low
3.2.2. Strict Government Rules and Regulation
3.3. Opportunities
3.3.1. Increasing Demand of Personalized Medicine
3.3.2. Development of Point of Care Testing
3.3.3. Advancement in Research and Development

4. Market Segmentation
4.1. Global Cardiac Biomarker Market, by Type
4.1.1. Creatine Kinase(Ck-Mb)
4.1.2. Troponins(T,I)
4.1.3. Myoglobin
4.1.4. Natriuretic Peptides (Bnp & Nt-Probnp)
4.1.5. Ischemia Modified Albumin
4.1.6. Others
4.2. Global Cardiac Biomarker Market, by Application
4.2.1. Myocardial Infraction
4.2.2. Congestive Heart Failure
4.2.3. Acute Coronary Syndrome
4.2.4. Atherosclerosis
4.2.5. Others
4.3. Global Cardiac Biomarker Market, by Location of Testing
4.3.1. Laboratory Testing
4.3.2. Point of Care Testing

5. Competitive Landscape
5.1. Strategy Analysis
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.4. Rest of the World

7. Company Profiles
7.1. Abbott Diagnostics
7.2. Alere Inc.
7.3. Becton, Dickson & Co.
7.4. Bg Medicine Inc.
7.5. Biomerieux
7.6. Bio-Rad Laboratories
7.7. Cisbio Bioassays
7.8. Covance
7.9. Critical Diagnostics
7.10. Lifesign
7.11. Luminex Corporation
7.12. Randox Laboratories Ltd.
7.13. Response Biomedical Corporation
7.14. Roche Holding Ag
7.15. Siemens Healthcare
7.16. Signosis Inc.
7.17. Thermo Fisher Scientific Inc.

List of Tables:
Table 1 Global Cardiac Biomarker Market Research and Analysis, by Geography , 2017-2023,
Table 2 Global Cardiac Biomarker Market Research and Analysis, by Type 2017-2023($ Million)
Table 3 Global Creatine Kinase (Ck-Mb) Market Research and Analysis, 2017-2023, ($ Million)
Table 4 Global Troponins (T,I) Market Research and Analysis, 2017-2023, ($ Million)
Table 5 Global Myoglobin Market Research and Analysis, 2017-2023, ($ Million)
Table 6 Global Natriuretic Peptides (Bnp-&Nt-Probnp) Market Research and Analysis, 2017-2023, ($ Million)
Table 7 Global Ischemia Modified Albumin Market Research and Analysis, 2017-2023, ($ Million)
Table 8 Global Others Market Research and Analysis, 2017-2023, ($ Million)
Table 9 Global Cardiac Biomarker Market Research and Analysis, by Application, 2017-2023, ($ Million)
Table 10 Global Myocardial Infraction Market Research and Analysis, 2017-2023, ($ Million)
Table 11 Global Congestive Heart Failure Market Research and Analysis, 2017-2023, ($ Million)
Table 12 Global Acute Coronary Syndrome Market Research and Analysis, 2017-2023, ($ Million)
Table 13 Global Atherosclerosis Market Research and Analysis, 2017-2023, ($ Million)
Table 14 Global Others Market Research and Analysis, 2017-2023, ($ Million)
Table 15 Global Cardiac Biomarker Market Research and Analysis, by Location of Testing 2017-2023, ($ Million)
Table 16 Global Laboratory Testing Market Research and Analysis, 2017-2023, ($ Million)
Table 17 Global Point of Care Testing Market Research and Analysis, 2017-2023, ($ Million)
Table 18 Merger and Acquisition
Table 19 Global Cardiac Biomarker Market, by Geography 2016-20122($ Million)
Table 20 North America Cardiac Biomarker Market Research and Analysis, by Type 2017-2023 ($Million)
Table 21 North America Cardiac Biomarker Market Research and Analysis, by Application 2017-2023 ($Million)
Table 22 North America Cardiac Biomarker Market Research and Analysis, by Location of Testing 2017-2023 ($Million)
Table 23 North America Cardiac Biomarker Market Research and Analysis, by Countries 2017-2023 ($Million)
Table 24 Europe Cardiac Biomarker Market Research and Analysis, by Type 2017-2023 ($Million)
Table 25 Europe Cardiac Biomarker Market Research and Analysis, by Application 2017-2023 ($Million)
Table 26 Europe Cardiac Biomarker Market Research and Analysis, by Location of Testing 2017-2023 ($Million)
Table 27 Europe Cardiac Biomarker Market Research and Analysis, by Countries 2017-2023 ($Million)
Table 28 Asia Pacific Cardiac Biomarker Market Research and Analysis, by Type 2017-2023 ($Million)
Table 29 Asia Pacific Cardiac Biomarker Market Research and Analysis, by Application 2017-2023 ($Million)
Table 30 Asia Pacific Cardiac Biomarker Market Research and Analysis, by Location of Testing 2017-2023 ($Million)
Table 31 Asia Pacific Cardiac Biomarker Market Research and Analysis, by Countries 2017-2023 ($Million)
Table 32 Rest of the World Biomarker Market Research and Analysis, by Type 2017-2023 ($Million)
Table 33 Rest of the World Cardiac Biomarker Market Research and Analysis, by Application 2017-2023 ($Million)
Table 34 Rest of the World Cardiac Biomarker Market Research and Analysis, by Location of Testing 2017-2023 ($Million)

List of Figures:
Figure 1 Global Cardiac Biomarker Market Share, by Type 2017 and 2023, (In %)
Figure 2 Global Cardiac Biomarker Market Share, by Application 2017 and 2023, (In %)
Figure 3 Global Cardiac Biomarker Market Share, by Location of Testing 2017 and 2023, (In %)
Figure 4 Global Cardiac Biomarker Market Share, by Geography 2017 and 2023, (In %)
Figure 5 North American Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 6 US Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 7 Canada Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 8 European Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 9 UK Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 10 France Market Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 11 Germany Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 12 Italy Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 13 Spain Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 14 ROE Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 15 Asia Pacific Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 16 India Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 17 China Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 18 Japan Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 19 RoAPAC Cardiac Biomarker Market Size, 2017-2023 ($Million)
Figure 20 Rest of the World Cardiac Biomarker Market Size, 2017-2023 ($Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Diagnostics
  • Alere Inc.
  • Becton, Dickson & Co.
  • Bg Medicine Inc.
  • Biomerieux
  • Bio-Rad Laboratories
  • Cisbio Bioassays
  • Covance
  • Critical Diagnostics
  • Lifesign
  • Luminex Corporation
  • Randox Laboratories Ltd.
  • Response Biomedical Corporation
  • Roche Holding AG
  • Siemens Healthcare
  • Signosis Inc.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll